K YU

489 total citations
5 papers, 395 citations indexed

About

K YU is a scholar working on Pediatrics, Perinatology and Child Health, Molecular Biology and Oncology. According to data from OpenAlex, K YU has authored 5 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pediatrics, Perinatology and Child Health, 2 papers in Molecular Biology and 2 papers in Oncology. Recurrent topics in K YU's work include Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). K YU is often cited by papers focused on Pharmacological Effects and Toxicity Studies (3 papers), Drug Transport and Resistance Mechanisms (2 papers) and Peroxisome Proliferator-Activated Receptors (2 papers). K YU collaborates with scholars based in South Korea. K YU's co-authors include In‐Jin Jang, Jae‐Yong Chung, Joo‐Youn Cho, Kyoung Soo Lim, Jin‐Tae Kim, Dal‐Seok Oh, Hae‐Yun Jung, Su‐Jung Shin, Heechul Jung and Ki Won Moon and has published in prestigious journals such as Clinical Pharmacology & Therapeutics.

In The Last Decade

K YU

5 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
K YU South Korea	4	248	197	154	61	45	5	395
A. K. Gonschior Germany	6	152 0.6×	128 0.6×	205 1.3×	67 1.1×	86 1.9×	10	438
Wen-Sheng Guo United States	5	401 1.6×	218 1.1×	324 2.1×	69 1.1×	59 1.3×	5	628
Kristin Westphal Germany	5	285 1.1×	144 0.7×	210 1.4×	25 0.4×	44 1.0×	6	406
Karla Köpke Germany	7	302 1.2×	106 0.5×	199 1.3×	65 1.1×	77 1.7×	10	485
R VANSCHAIK Netherlands	5	180 0.7×	87 0.4×	137 0.9×	46 0.8×	46 1.0×	6	386
Priyamvada Chandra United States	9	310 1.3×	162 0.8×	145 0.9×	77 1.3×	36 0.8×	14	454
Yohei Nishizato Japan	4	304 1.2×	159 0.8×	166 1.1×	91 1.5×	45 1.0×	6	435
Cornelia Remmler Germany	7	246 1.0×	75 0.4×	160 1.0×	57 0.9×	39 0.9×	8	367
Anneke Nina Werk Germany	10	211 0.9×	221 1.1×	105 0.7×	53 0.9×	49 1.1×	12	590
Mark Goldammer Germany	7	176 0.7×	203 1.0×	156 1.0×	51 0.8×	21 0.5×	12	479

Countries citing papers authored by K YU

Since Specialization

Citations

This map shows the geographic impact of K YU's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K YU with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K YU more than expected).

Fields of papers citing papers by K YU

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K YU. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K YU. The network helps show where K YU may publish in the future.

Co-authorship network of co-authors of K YU

This figure shows the co-authorship network connecting the top 25 collaborators of K YU. A scholar is included among the top collaborators of K YU based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K YU. K YU is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

5 of 5 papers shown

1.

Lim, Keunpoong, et al.. (2006). PII-15Safety, tolerability, and pharmacokineticsof CKD-501, a novel peroxisome proliferator-activated receptor alpha/gamma dual agonist after oral administration. Clinical Pharmacology & Therapeutics. 79(2). P39–P39. 1 indexed citations

2.

Chung, Jae‐Yong, Joo‐Youn Cho, K YU, et al.. (2005). Effect of the genotype on the pharmacokinetics, pharmacodynamics, and drug interactions of intravenous lorazepam in healthy volunteers. Clinical Pharmacology & Therapeutics. 77(6). 486–494. 79 indexed citations

3.

Chung, Jae‐Yong, Joo‐Youn Cho, K YU, et al.. (2005). Effect of () variant alleles on the pharmacokinetics of pitavastatin in healthy volunteers. Clinical Pharmacology & Therapeutics. 78(4). 342–350. 137 indexed citations

4.

Yi, Sun Young, Kui Hong, Hoong Sern Lim, et al.. (2004). A variant 2677A allele of the gene affects fexofenadine disposition. Clinical Pharmacology & Therapeutics. 76(5). 418–427. 91 indexed citations

5.

YU, K. (2004). Effect of the CYP3A5 genotype on the pharmacokinetics of intravenous midazolam during inhibited and induced metabolic states*1. Clinical Pharmacology & Therapeutics. 76(2). 104–112. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact